{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:32:28Z","timestamp":1776396748331,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00125-004-1507-3","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T07:06:58Z","timestamp":1096960018000},"page":"1661-1667","source":"Crossref","is-referenced-by-count":186,"title":["Insulin resistance is a risk factor for progression to Type 1 diabetes"],"prefix":"10.1007","volume":"47","author":[{"given":"S.","family":"Fourlanos","sequence":"first","affiliation":[]},{"given":"P.","family":"Narendran","sequence":"additional","affiliation":[]},{"given":"G. B.","family":"Byrnes","sequence":"additional","affiliation":[]},{"given":"P. G.","family":"Colman","sequence":"additional","affiliation":[]},{"given":"L. C.","family":"Harrison","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,10,6]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.46.11.1701","volume":"46","author":"Bingley","year":"1997","unstructured":"Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA (1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701?1710","journal-title":"Diabetes"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/diabetes.47.12.1857","volume":"47","author":"Verge","year":"1998","unstructured":"Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857?1866","journal-title":"Diabetes"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1399-5448.2001.002002071.x","volume":"2","author":"Harrison","year":"2001","unstructured":"Harrison LC (2001) Risk assessment, prediction and prevention of type 1 diabetes. Pediatr Diabetes 2:71?82","journal-title":"Pediatric Diabetes"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/diacare.24.2.398","volume":"24","author":"Bingley","year":"2001","unstructured":"Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS (2001) Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 24:398","journal-title":"Diabetes Care"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663?1672","journal-title":"Diabetes"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM198607243150404","volume":"315","author":"Yki-Jarvinen","year":"1986","unstructured":"Yki-Jarvinen H, Koivisto VA (1986) Natural course of insulin resistance in type I diabetes. N Engl J Med 315:224?230","journal-title":"N Engl J Med"},{"key":"CR7","first-page":"7","volume":"Endocrinol","author":"Smith","year":"1988","unstructured":"Smith CP, Archibald HR, Thomas JM et al. (1988) Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol (Oxf) 28:7?14","journal-title":"Clin"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0002-9378(91)90012-G","volume":"165","author":"Catalano","year":"1991","unstructured":"Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA (1991) Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 165:1667?1672","journal-title":"Am J Obstet Gynecol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/dmrr.291","volume":"18","author":"Greenbaum","year":"2002","unstructured":"Greenbaum CJ (2002) Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 18:192?200","journal-title":"Diabetes Metab Res Rev"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.294.6567.275","volume":"294","author":"Buschard","year":"1987","unstructured":"Buschard K, Buch I, M\u00f8lsted-Pedersen L, Hougaard P, K\u00fchl C (1987) Increased incidence of true type 1 diabetes acquired during pregnancy. BMJ 294:275?279","journal-title":"BMJ"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/diab.39.5.549","volume":"39","author":"McCulloch","year":"1990","unstructured":"McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 39:549?556","journal-title":"Diabetes"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/endo.139.3.5823","volume":"139","author":"Amrani","year":"1998","unstructured":"Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F (1998) Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 139:1115?1124","journal-title":"Endocrinology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/dmrr.262","volume":"18","author":"Beales","year":"2002","unstructured":"Beales PE, Pozzilli P (2002) Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev 18:114?117","journal-title":"Diabetes Metab Res Rev"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5694\/j.1326-5377.1998.tb140188.x","volume":"169","author":"Colman","year":"1998","unstructured":"Colman PG, McNair P, Margetts H et al. (1998) The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust 169:81?84","journal-title":"Med J Aust"},{"key":"CR15","unstructured":"American Diabetes Association (2002) Clinical Practice Recommendations 2002. Diabetes Care 25 [Suppl 1]:S1?S147"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2337\/diab.36.11.1286","volume":"36","author":"Vardi","year":"1987","unstructured":"Vardi P, Dib SA, Tuttleman M et al. (1987) Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 36:1286?1291","journal-title":"Diabetes"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/diab.43.3.459","volume":"43","author":"Petersen","year":"1994","unstructured":"Petersen JS, Hejnaes KR, Moody A et al. (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459?467","journal-title":"Diabetes"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2337\/diacare.15.10.1313","volume":"15","author":"Bingley","year":"1992","unstructured":"Bingley PJ, Colman P, Eisenbarth GS et al. (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15:1313?1316","journal-title":"Diabetes Care"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2337\/diacare.18.8.1168","volume":"18","author":"McNair","year":"1995","unstructured":"McNair PD, Colman PG, Alford FP, Harrison LC (1995) Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18:1168?1173","journal-title":"Diabetes Care"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412?419","journal-title":"Diabetologia"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.20.7.1087","volume":"20","author":"Haffner","year":"1997","unstructured":"Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087?1092","journal-title":"Diabetes Care"},{"key":"CR22","first-page":"4426","volume":"85","author":"Radziuk","year":"2000","unstructured":"Radziuk J (2000) Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426?4433","journal-title":"J Clin Endocrinol Metab"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57?63","journal-title":"Diabetes Care"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s001250051215","volume":"42","author":"Hermans","year":"1999","unstructured":"Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678?687","journal-title":"Diabetologia"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","volume":"24","author":"Katsuki","year":"2001","unstructured":"Katsuki A, Sumida Y, Gabazza EC et al. (2001) Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24:362?365","journal-title":"Diabetes Care"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/diacare.22.5.818","volume":"22","author":"Emoto","year":"1999","unstructured":"Emoto M, Nishizawa Y, Maekawa K et al. (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818?822","journal-title":"Diabetes Care"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","volume":"19","author":"Wallace","year":"2002","unstructured":"Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527?534","journal-title":"Diabet Med"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(00)02612-X","volume":"356","author":"Bruining","year":"2000","unstructured":"Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655?656","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.326.7390.624","volume":"326","author":"McCarthy","year":"2003","unstructured":"McCarthy HD, Ellis SM, Cole TJ (2003) Central overweight and obesity in British youth aged 11?16 years: cross sectional surveys of waist circumference. BMJ 326:624","journal-title":"BMJ"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-8411(09)90010-5","volume":"3","author":"Campbell","year":"1990","unstructured":"Campbell IL, Harrison LC (1990) A new view of the beta cell as an antigen-presenting cell and immunogenic target. J Autoimmun 3:53?62","journal-title":"J Autoimmun"},{"key":"CR31","first-page":"859","volume":"83","author":"Katsuki","year":"1998","unstructured":"Katsuki A, Sumida Y, Murashima S et al. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859?862","journal-title":"J Clin Endocrinol Metab"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jcem.86.9.7873","volume":"86","author":"Hak","year":"2001","unstructured":"Hak AE, Pols HA, Stehouwer CD et al. (2001) Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86:4398?4405","journal-title":"J Clin Endocrinol Metab"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jcem-48-1-59","volume":"48","author":"Harrison","year":"1979","unstructured":"Harrison LC, Flier JS, Roth J, Karlsson FA, Kahn CR (1979) Immunoprecipitation of the insulin receptor: a sensitive assay for receptor antibodies and a specific technique for receptor purification. J Clin Endocrinol Metab 48:59?65","journal-title":"J Clin Endocrinol Metab"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F et al. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851?860","journal-title":"J Clin Invest"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diabetes.50.8.1683","volume":"50","author":"Maedler","year":"2001","unstructured":"Maedler K, Spinas GA, Lehmann R et al. (2001) Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683?1690","journal-title":"Diabetes"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diab.39.6.697","volume":"39","author":"Aaen","year":"1990","unstructured":"Aaen K, Rygaard J, Josefsen K et al. (1990) Dependence of antigen expression on functional state of beta-cells. Diabetes 39:697?701","journal-title":"Diabetes"},{"key":"CR37","first-page":"1574","volume":"75","author":"Bjork","year":"1992","unstructured":"Bjork E, Kampe O, Karlsson FA et al. (1992) Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab 75:1574?1576","journal-title":"J Clin Endocrinol Metab"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2337\/diabetes.48.4.738","volume":"48","author":"Donath","year":"1999","unstructured":"Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738?744","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-004-1507-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-004-1507-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-004-1507-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:15:06Z","timestamp":1585901706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-004-1507-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1007\/s00125-004-1507-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}